Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04022876
Title A Study of ALRN-6924 for the Prevention of Chemotherapy-induced Side Effects (Chemoprotection)
Recruitment Terminated
Gender
Phase Phase I
Variant Requirements Yes
Sponsors Aileron Therapeutics, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | POL | ITA | ESP | DEU

Additional content available in CKB BOOST